Monopar Therapeutics Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold00000000
Gross Profit00000000
R&D Expenses3.5M3.9M2.6M1.7M1.6M9.9M984K1.1M
Operating Expenses5.2M6.2M4.1M3.2M3.2M11.1M1.6M1.8M
Operating Income-5.2M-6.2M-4.1M-3.2M-3.2M-11.1M-1.6M-1.8M
Other Income / Gains1.3M954K655K781K597K149K271K73K
Net Income-3.9M-5.2M-3.4M-2.5M-2.6M-10.9M-1.3M-1.7M
EPS (Diluted)-0.46-0.78-0.48-0.35-0.38-0.95-0.11-0.15
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses1.74B2.2M1.5M1.5M1.6M1.2M591K658K
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses1.74B2.2M1.5M1.5M1.6M1.2M591K658K
Other Expenses-1.74B0-1.0000000
Cost And Expenses5.2M6.2M4.1M3.2M3.2M11.1M1.6M1.8M
Interest Income1.3M954K655K781K597K149K99K73K
Interest Expense00000000
Depreciation And Amortization00000000
Ebitda-3.9M-5.2M-4.1M-2.5M-2.6M-10.9M-1.3M-1.7M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-3.9M-5.2M-3.4M-2.5M-2.6M-10.9M-1.3M-1.7M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-0.46-0.78-0.48-0.35-0.38-0.95-0.11-0.15
Weighted Average Shs Out8.5M6.7M7.1M7.0M6.9M11.4M11.4M11.4M
Weighted Average Shs Out Dil8.5M6.7M7.1M7.0M7.0M11.5M11.5M11.5M